@cavepunch75
Long-term efficacy as well as security involving inebilizumab in neuromyelitis optica range problem: Analysis regarding aquaporin-4-immunoglobulin G-seropositive contributors using inebilizumab with regard to ⩾4 years from the N-MOmentum test.